Dusseldorf - Delayed Quote EUR

Agios Pharmaceuticals Inc (8AP.DU)

25.20
-0.20
(-0.79%)
As of 4:32:17 PM GMT+2. Market Open.
Loading Chart for 8AP.DU
  • Previous Close 25.40
  • Open 25.40
  • Bid 24.60 x --
  • Ask 25.20 x --
  • Day's Range 25.20 - 25.40
  • 52 Week Range 21.40 - 58.00
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 8AP.DU

View More

Performance Overview: 8AP.DU

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

8AP.DU
19.75%
S&P 500 (^GSPC)
0.14%

1-Year Return

8AP.DU
18.18%
S&P 500 (^GSPC)
12.26%

3-Year Return

8AP.DU
20.00%
S&P 500 (^GSPC)
46.38%

5-Year Return

8AP.DU
39.28%
S&P 500 (^GSPC)
106.49%

Compare To: 8AP.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8AP.DU

View More

Valuation Measures

As of 5/13/2025
  • Market Cap

    1.50B

  • Enterprise Value

    742.65M

  • Trailing P/E

    2.44

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    44.26

  • Price/Book (mrq)

    1.11

  • Enterprise Value/Revenue

    22.25

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 8AP.DU

View More